Nanocrystalline Ce(1-x)Fe(x)O(2-δ) (0 ≤ x ≤ 0.45) and Ce(0.65)Fe(0.33)Pd(0.02)O(2-δ) of ~4 nm sizes were synthesized by a sonochemical method using diethyletriamine (DETA) as a complexing agent. Compounds were characterized by powder X-ray diffraction (XRD), X-ray photo-electron spectroscopy (XPS) and transmission electron microscopy (TEM). Ce(1-x)Fe(x)O(2-δ) (0 ≤ x ≤ 0.45) and Ce(0.65)Fe(0.33)Pd(0.02)O(2-δ) crystallize in fluorite structure where Fe is in +3, Ce is in +4 and Pd is in +2 oxidation state. Due to substitution of smaller Fe(3+) ion in CeO(2), lattice oxygen is activated and 33% Fe substituted CeO(2)i.e. Ce(0.67)Fe(0.33)O(1.835) reversibly releases 0.31[O] up to 600 °C which is higher or comparable to the oxygen storage capacity of CeO(2)-ZrO(2) based solid solutions (Catal. Today 2002, 74, 225-234). Due to interaction of redox potentials of Pd(2+/0)(0.89 V) and Fe(3+/2+) (0.77 V) with Ce(4+/3+) (1.61 V), Pd ion accelerates the electron transfer from Fe(2+) to Ce(4+) in Ce(0.65)Fe(0.33)Pd(0.02)O(1.815), making it a high oxygen storage material as well as a highly active catalyst for CO oxidation and water gas shift reaction. The activation energy for CO oxidation with Ce(0.65)Fe(0.33)Pd(0.02)O(1.815) is found to be as low as 38 kJ mol(-1). Ce(0.67)Fe(0.33)O(1.835) and Ce(0.65)Fe(0.33)Pd(0.02)O(1.815) have also shown high activity for the water gas shift reaction. CO conversion to CO(2) is 100% H(2) specific with these catalysts and conversion rate was found to be as high 27.2 μmoles g(-1) s(-1) and the activation energy was found to be 46.4 kJ mol(-1) for Ce(0.65)Fe(0.33)Pd(0.02)O(1.815).
No takes yet. Share an insight, caveat, or question.
Singh et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: